129 related articles for article (PubMed ID: 15194366)
1. African-American ethnicity is no longer a risk factor for early adverse outcomes in simultaneous kidney-pancreas transplantation with contemporary immunosuppression.
Rogers J; Stratta RJ; Alloway RR; Lo A; Hodge EE
Transplant Proc; 2004 May; 36(4):1055-7. PubMed ID: 15194366
[TBL] [Abstract][Full Text] [Related]
2. Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipients.
Rogers J; Stratta RJ; Lo A; Alloway RR
Transplant Proc; 2005 Oct; 37(8):3552-4. PubMed ID: 16298658
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
Stratta RJ; Alloway RR; Hodge E; Lo A;
Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617
[TBL] [Abstract][Full Text] [Related]
4. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression.
Stratta RJ; Shokouh-Amiri MH; Egidi MF; Grewal HP; Lo A; Kizilisik AT; Nezakatgoo N; Gaber LW; Gaber AO
Clin Transplant; 2003; 17 Suppl 9():69-77. PubMed ID: 12795673
[TBL] [Abstract][Full Text] [Related]
5. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
Stratta RJ; Alloway RR; Lo A; Hodge E
Transplantation; 2003 Apr; 75(8):1260-6. PubMed ID: 12717213
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study.
Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kizilisik AT; Alloway RR; Gaber LW; Gaber AO
Clin Transplant; 2000 Dec; 14(6):572-9. PubMed ID: 11127311
[TBL] [Abstract][Full Text] [Related]
7. One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumab.
Stratta RJ; Alloway RR; Lo A; Hodge EE;
Transplant Proc; 2004 May; 36(4):1080-1. PubMed ID: 15194375
[TBL] [Abstract][Full Text] [Related]
8. Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
Bruce DS; Sollinger HW; Humar A; Sutherland DE; Light JA; Kaufman DB; Alloway RR; Lo A; Stratta RJ
Transplantation; 2001 Nov; 72(10):1637-43. PubMed ID: 11726823
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years.
Stratta RJ; Alloway RR; Lo A; Hodge EE
Transplant Proc; 2005 Oct; 37(8):3531-4. PubMed ID: 16298651
[TBL] [Abstract][Full Text] [Related]
10. Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation.
Rogers J; Baliga PK; Chavin KD; Lin A; Emovon O; Afzal F; Baillie GM; Ashcraft EE; Rajagopalan PR
Am J Transplant; 2003 Oct; 3(10):1278-88. PubMed ID: 14510702
[TBL] [Abstract][Full Text] [Related]
11. Does surgical technique influence outcomes after simultaneous kidney-pancreas transplantation?
Stratta RJ; Alloway RR; Lo A; Hodge EE;
Transplant Proc; 2004 May; 36(4):1076-7. PubMed ID: 15194373
[TBL] [Abstract][Full Text] [Related]
12. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco.
Vincenti F; Stock P
Transplant Proc; 2003 May; 35(3 Suppl):183S-186S. PubMed ID: 12742494
[TBL] [Abstract][Full Text] [Related]
13. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.
Lo A; Stratta RJ; Alloway RR; Hodge EE;
Transplant Proc; 2005 Mar; 37(2):1289-90. PubMed ID: 15848699
[TBL] [Abstract][Full Text] [Related]
14. Pancreas transplantation: The Wake Forest experience in the new millennium.
Rogers J; Farney AC; Orlando G; Iskandar SS; Doares W; Gautreaux MD; Kaczmorski S; Reeves-Daniel A; Palanisamy A; Stratta RJ
World J Diabetes; 2014 Dec; 5(6):951-61. PubMed ID: 25512802
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of single pediatric donor kidney transplants between African-American and non-African-American adults.
Paramesh A; Zhang R; Yau CL; Balamuthusamy S; Shenava R; Killackey M; Alper B; Simon E; Slakey D; Florman S
Clin Nephrol; 2009 Jul; 72(1):55-61. PubMed ID: 19640388
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes in African American kidney transplant recipients under contemporary immunosuppression: a four-yr analysis of the Mycophenolic acid Observational REnal transplant (MORE) study.
Narayanan M; Pankewycz O; Shihab F; Wiland A; McCague K; Chan L
Clin Transplant; 2014 Feb; 28(2):184-91. PubMed ID: 24372743
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of highly sensitized African American patients transplanted with deceased donor kidneys.
Ren Q; Paramesh A; Yau CL; Killackey M; Slakey D; Florman S; Buell J; Alper B; Simon E; Hamm LL; Zhang R
Transpl Int; 2011 Mar; 24(3):259-65. PubMed ID: 21091553
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
Stratta RJ; Alloway RR; Lo A; Hodge EE
Transplant Proc; 2005 Oct; 37(8):3527-30. PubMed ID: 16298650
[TBL] [Abstract][Full Text] [Related]
19. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation.
Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber LW; Gaber AO
Transpl Int; 2001 Dec; 14(6):396-404. PubMed ID: 11793037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
